Kazia Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement
Kazia Therapeutics(KZIA) Prnewswire·2024-05-23 18:41
If at any time during the Second Compliance Period the closing bid price of the Company's security is at least $1.00 per share for a minimum of 10 consecutive business days, Nasdaq will provide written confirmation of compliance. Nasdaq's determination was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and th ...